| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/06/2011 | CN102000313A Medicament for treating rheumatic arthritis and preparation method thereof |
| 04/06/2011 | CN102000306A Traditional Chinese medicine external patch for treating rheumatism and rheumatoid diseases |
| 04/06/2011 | CN102000305A Traditional Chinese medical preparation for treating gout |
| 04/06/2011 | CN102000296A Medicament for treating periarthritis of shoulder |
| 04/06/2011 | CN102000276A External plaster for promoting blood circulation and removing blood stasis and preparation method thereof |
| 04/06/2011 | CN102000268A Oral traditional Chinese medical preparation for treating rheumatism and rheumatoid diseases |
| 04/06/2011 | CN102000235A Externally-applied health-care medicinal wine |
| 04/06/2011 | CN102000234A Quick bone-setting powder |
| 04/06/2011 | CN102000233A Oral traditional Chinese medicine for knife wounds |
| 04/06/2011 | CN102000231A Medicine composition for treating osteopathic diseases |
| 04/06/2011 | CN102000228A Bathing method for adjuvant therapy of arthralgia |
| 04/06/2011 | CN102000202A Traditional Chinese medicine for treating scleroderma |
| 04/06/2011 | CN102000201A Method for preparing anti-hyperosteogeny tablets |
| 04/06/2011 | CN102000198A Anti-hyperosteogeny Chinese herbal medicine prescription |
| 04/06/2011 | CN102000173A Medicinal liquor formula for treating prolapse of lumbar intervertebral disc |
| 04/06/2011 | CN102000171A Traditional Chinese medicine for treating ostalgia |
| 04/06/2011 | CN102000165A Traditional Chinese medicinal composition for treating fracture and preparation method thereof |
| 04/06/2011 | CN102000161A External traditional Chinese medicine packet for treating caput femoris necrosis |
| 04/06/2011 | CN102000160A Luodwei dorjie granules and preparation method thereof |
| 04/06/2011 | CN102000159A Composition with effect of treating gout |
| 04/06/2011 | CN102000116A Traditional Chinese medicine for treating rheumatoid arthritis |
| 04/06/2011 | CN102000110A Composition used for preventing or treating bone and joint diseases and preparation method thereof |
| 04/06/2011 | CN102000078A Compound raloxifene hydrochloride tablets and preparation method thereof |
| 04/06/2011 | CN102000053A Application of paclitaxel and derivants thereof in pharmacy field |
| 04/06/2011 | CN102000052A Application of taxol and taxol derivatives to pharmacy |
| 04/06/2011 | CN102000047A Antrodia camphorata cyclonene compound for restraining growth of bone cancer cells |
| 04/06/2011 | CN102000040A Febuxostat capsule drug combination and preparation method thereof |
| 04/06/2011 | CN102000035A Zoledronic acid composition for injection and preparation method thereof |
| 04/06/2011 | CN102000029A Strontium ranelate dry suspension |
| 04/06/2011 | CN102000018A Solid dispersion containing celecoxib as well as preparation method and application thereof |
| 04/06/2011 | CN101716266B Medicaments for treating fractures and preparation method thereof |
| 04/06/2011 | CN101703662B Oral Chinese medicament for treating hyperosteogeny |
| 04/06/2011 | CN101647976B Medicine for treating bovine osteomalacia |
| 04/06/2011 | CN101642535B Medicinal composition for treating gout |
| 04/06/2011 | CN101612279B Chinese medicine preparation for promoting fracture healing |
| 04/06/2011 | CN101590183B Application of medicinal composition in preparing medicaments for treating fracture |
| 04/06/2011 | CN101548801B Jacket for treating shoulder pain, knee joint pain and chronic bronchitis |
| 04/06/2011 | CN101536857B Healthcare pillow for treating periarthritis humeroscapularis and cervical spondylosis |
| 04/06/2011 | CN101530442B Asarum volatile oil prepared by vacuum distillation method and use thereof |
| 04/06/2011 | CN101518573B External pulvis for treating rheumatoid arthritis |
| 04/06/2011 | CN101491529B Preparation method of piroxicam belta-cyclodextrin inclusion compound micro-pill capsules |
| 04/06/2011 | CN101422531B Wind-expelling pain-assuaging paste capable of treating lumbar intervertebral disc protrusion |
| 04/06/2011 | CN101361829B Traditional Chinese medicine for treating rheumatism, atrophic arthritis and preparation method thereof |
| 04/06/2011 | CN101317818B Methopterin intralipid, its freeze drying agent, preparation method and application thereof |
| 04/06/2011 | CN101293894B Preparing intermediate of 2-propylidene-19-nor-vitamin D compounds |
| 04/06/2011 | CN101293042B Medicament for treating necrosis of femoral head |
| 04/06/2011 | CN101185621B Chinese medicinal herb antimicrobial hand cleanser and preparation method thereof |
| 04/06/2011 | CN101181399B Chinese medicine preparation for curing podosoma exogenous injury and rheumatism ache as well as producing method thereof |
| 04/06/2011 | CN101116747B Cytosine arabinoside and gland correlated virus composite preparations and uses thereof |
| 04/06/2011 | CN101023982B Medicine composition for treating osteoporosis |
| 04/06/2011 | CN101011505B Externally used medicament for treating osteoarthrosis and preparation method thereof |
| 04/05/2011 | WO2010045415A2 Topical nsaid compositions having sensate component |
| 04/05/2011 | US7919513 Inhibitors of p38 |
| 04/05/2011 | US7919507 N-aroyl cyclic amines |
| 04/05/2011 | US7919498 Substituted pyrazolo[3,4-d]pyrimidines as PI3K inhibitors |
| 04/05/2011 | US7919456 Connective tissue derived polypeptides |
| 04/05/2011 | US7919255 Assessment of skeletal growth using measurements of NT-CNP peptides |
| 04/05/2011 | US7919091 Lipolysis stimulated receptor (LSR) specific antibodies |
| 04/05/2011 | CA2739682A1 Topical nsaid compositions having sensate component |
| 04/05/2011 | CA2514681C Methods and compositions for inhibition of angiogenesis |
| 04/05/2011 | CA2496040C Derivatives of dioxan-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 04/05/2011 | CA2494695C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 04/05/2011 | CA2466170C Hexa-, hepta-, and octapeptides having antiangiogenic activity |
| 04/05/2011 | CA2360326C Use of 4-amino pyridine for treatment of peripheral neuropathies |
| 04/05/2011 | CA2346119C A method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5 |
| 03/31/2011 | WO2011038230A2 Compositions and methods for the prevention and treatment of metabolic diseases |
| 03/31/2011 | WO2011038015A1 Method of treating osteoporosis with a neurotoxin |
| 03/31/2011 | WO2011037467A1 Atazanavir for treating inflammatory diseases |
| 03/31/2011 | WO2011037355A2 Pharmaceutical composition for treating and preventing diseases involving joints and connective tissue |
| 03/31/2011 | WO2011036895A1 Maleic acid salt and crystal thereof |
| 03/31/2011 | WO2011036632A1 Composition comprising a haematic component and its use for the treatment of degenerative joint disease |
| 03/31/2011 | WO2011036461A1 Fused imidazo [3, 2 - d] pyrazines as pi3 kinase inhibitors |
| 03/31/2011 | WO2011019153A3 Composition for preventing or treating arthritis, containing an extract of an herbal medicine mixture of schisandra chinensis baillon, scutellaria baicalensis and kalopanax pictus nakai as an active ingredient |
| 03/31/2011 | WO2010151740A3 Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases |
| 03/31/2011 | WO2010108187A3 Compounds and methods for treating mammalian gastrointestinal microbial infections |
| 03/31/2011 | WO2010088408A3 Subunit selective nmda receptor antagonists for the treatment of neurological conditions |
| 03/31/2011 | WO2009129246A3 Compositions and methods for preparing and using same |
| 03/31/2011 | US20110077299 Inhibitors of alpha4 mediated cell adhesion |
| 03/31/2011 | US20110077269 Derivatives for modulation of ion channels |
| 03/31/2011 | US20110077268 Kinase inhibitors and methods of use |
| 03/31/2011 | US20110077254 Compounds |
| 03/31/2011 | US20110077252 Pyridyl derivatives, their preparation and use |
| 03/31/2011 | US20110077249 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives |
| 03/31/2011 | US20110077245 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 03/31/2011 | US20110077243 Triazolopyridine Compounds Useful As Kinase Inhibitors |
| 03/31/2011 | US20110077235 Apoptosis signal-regulating kinase 1 inhibitors |
| 03/31/2011 | US20110077194 Method for Treating or Preventing a Functional Vitamin B12 Deficiency in an Individual and to Medical Compositions for Use in Said Method |
| 03/31/2011 | US20110077190 Selective Caspase Inhibitors and Uses Thereof |
| 03/31/2011 | US20110076345 Herbal Formulation for the Treatment of Bone Fractures and Osseous Defects |
| 03/31/2011 | US20110076344 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 03/31/2011 | US20110076332 Dextran-chitosan based in-situ gelling hydrogels for biomedical applications |
| 03/31/2011 | US20110076330 Use of adipose tissue-derived stromal cells in spinal fusion |
| 03/31/2011 | US20110076322 Amphoteric liposomes |
| 03/31/2011 | US20110076316 Scalable matrix for the in vivo cultivation of bone and cartilage |
| 03/31/2011 | US20110076295 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 03/31/2011 | US20110076294 Mixed Cell Populations For Tissue Repair And Separation Technique For Cell Processing |
| 03/31/2011 | US20110076293 Triptolide derivatives for modulation of apoptosis and immunosuppression |
| 03/31/2011 | US20110076279 Fully human anti-vegf antibodies and methods of using |
| 03/31/2011 | US20110076267 Humanized antibody compositions and methods for binding lysophosphatidic acid |
| 03/31/2011 | US20110076264 Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such |